Simplex Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-66
| Closed | -$22K | – | 8390 |
|
|
2018
Q3 | $22K | Buy |
66
+49
| +288% | +$177 | ﹤0.01% | 5905 |
|
|
2018
Q2 | $6K | Sell |
17
-13
| -43% | -$63 | ﹤0.01% | 6667 |
|
|
2018
Q1 | $2K | Sell |
30
-85
| -74% | -$396 | ﹤0.01% | 5466 |
|
|
2017
Q4 | $6K | Buy |
115
+98
| +576% | +$540 | ﹤0.01% | 4430 |
|
|
2017
Q3 | $2K | Sell |
17
-21
| -55% | -$151 | ﹤0.01% | 5282 |
|
|
2017
Q2 | $12K | Sell |
38
-9
| -19% | -$56 | ﹤0.01% | 3857 |
|
|
2017
Q1 | $17K | Sell |
47
-81
| -63% | -$444 | ﹤0.01% | 3459 |
|
|
2016
Q4 | $29K | Buy |
128
+10
| +8% | +$55 | ﹤0.01% | 2711 |
|
|
2016
Q3 | $39K | Buy |
118
+110
| +1,375% | +$593 | ﹤0.01% | 2340 |
|
|
2016
Q2 | $6K | Sell |
8
-51
| -86% | -$285 | ﹤0.01% | 4172 |
|
|
2016
Q1 | $10K | Buy |
59
+13
| +28% | +$52 | ﹤0.01% | 3522 |
|
|
2015
Q4 | $13K | Buy |
46
+34
| +283% | +$162 | ﹤0.01% | 3116 |
|
|
2015
Q3 | $11K | Sell |
12
-133
| -92% | -$891 | ﹤0.01% | 3382 |
|
|
2015
Q2 | $24K | Buy |
145
+102
| +237% | +$1.09K | ﹤0.01% | 2318 |
|
|
2015
Q1 | $10K | Sell |
43
-48
| -53% | -$617 | ﹤0.01% | 2974 |
|
|
2014
Q4 | $16K | Buy |
+91
| New | +$1.41K | ﹤0.01% | 2244 |
|
Simplex Trading's KERX Position: Q4 2018 in Review
Simplex Trading sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 5,600 shares — an estimated $19K sold.
Simplex Trading first reported a position in KERX in Q1 2015 and held it in 9 quarters. The position peaked at $153K in Q3 2016. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Simplex Trading reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Simplex Trading sold 5,600 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $19K.
- Simplex Trading first reported a position in Keryx Biopharmaceuticals Inc in Q1 2015 and held it in 9 quarters.
- Simplex Trading's Keryx Biopharmaceuticals Inc position peaked at $153K in Q3 2016.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Simplex Trading's 13F filing for Q4 2018, filed 16 Jan 2019.